Hearing threshold in preterm and term infantsby auditory brainstem response1
References (31)
- et al.
Follow-up of infants screened by auditory brainstem response in the neonatal intensive care unit
J Pediatr
(1983) - et al.
Brainstem evoked response audiometry in the premature infant population
Int J Pediatr Otorhinolaryngol
(1981) - et al.
Auditory brainstem responses in preterm neonates. Maturation and follow-up
J Pediatr
(1982) Identification of hearing loss in infants and young children
Otolaryngol Clin North Am
(1978)- et al.
Clinical assessment of gestational age in the newborn infant
J Pediatr
(1970) - et al.
Postnatal development of human brainstem potentials during the first year of life
Electroencephalogr and Clin Neurophysiol
(1976) - et al.
Cochlear audiometry (electrocochleography) during the neonatal period
Dev Med Child Neurol
(1973) - et al.
Routine use of electrocochleography (cochlear audiometry) on human subjects
Audiology
(1973) - et al.
Evaluation of the auditory system: an update
Ann Otol Rhinol Laryngol
(1983) Computing false positive and false negative sites for the crib-o-gram
J Speech Hear Disord
(1982)
Long term follow-up of newborns tested with the auditory response cradle
Arch Dis Child
Development of auditory function in newborn infants revealed by auditory brainstem potentials
Pediatrics
Hearing defects in preterm infants
Arch Dis Child
Assessment of hearing
Auditory brainstem response in neurologically normal pretern and full-term newborn infants
Neuropediatrics
Cited by (97)
Use of sound-elicited fetal heart rate accelerations to assess fetal hearing in the second and third trimester
2020, International Journal of Pediatric OtorhinolaryngologyCitation Excerpt :On the other hand, the presence and absence of FHR accelerations were independent of the FHR baseline variability, namely sleep conditions, during 20–27 weeks GA. Regarding the development of human fetal hearing, previous studies have reported that the auditory brainstem response occurs in premature infants at 25–28 weeks GA [11–13], and the appearance of otoacoustic emissions at 33 weeks GA [14]. Thus, the unstable appearance of sound-elicited FHR accelerations during 20–27 weeks GA may be brought about by individual differences in the development of auditory pathways.
Evaluation of fetal exposure to external loud noise using a sheep model: quantification of in utero acoustic transmission across the human audio range
2019, American Journal of Obstetrics and GynecologyPiezoelectric vibrator-stimulated potential and heart rate accelerations detected from the fetus
2017, International Journal of Pediatric OtorhinolaryngologyCitation Excerpt :The fetus is well known to have a substantial capacity for sound recognition in the uterine environment [1]. In premature human infants [2–4], auditory-evoked potentials can be recorded from 25 to 28 weeks gestational age (GA), and otoacoustic emissions are elicited as early as 30 weeks GA [5]. Furthermore, a number of studies revealed fetal cortical activation in response to auditory stimuli using both magnetic resonance imaging and magnetoencephalography [6].
Early Development of the Human Auditory System
2017, Fetal and Neonatal Physiology, 2-Volume SetComparison of maturational process of hearing threshold in early life between at-risk and low-risk preterm infants
2016, Early Human DevelopmentCitation Excerpt :As a well-documented good objective estimate of peripheral auditory sensitivity, the threshold of brainstem auditory evoked response (BAER) has been widely used to assess peripheral hearing in infants and children [2–8]. The BAER can be recorded in preterm infants at as early as 26–28 weeks of gestation [5,9,10]. Shortly after birth, the threshold of BAER in preterm infants is higher than that in term infants, and then decreases with increasing age, from 30 to 40 dB nHL at 28 weeks to 10–20 dB at term date.
Designing artificial circadian environments with multisensory cares for supporting preterm infants’ growth in NICUs
2023, Frontiers in Neuroscience
- 1
Supported by the National Fund for Research into Crippling Diseases (Action Research) and the Medical Research Council.